Results 1 to 10 of about 1,296 (168)
Availability of Oral Emergency Contraception in German Community Pharmacies-A Nationwide Cross-Sectional Mystery Caller Study. [PDF]
Health Sci RepABSTRACT Background and Aims In Germany, the “morning after pill” (oral emergency contraception [EC]), which contains the active ingredients ulipristal acetate (UPA) and levonorgestrel (LNG), can only be dispensed by community pharmacies (CPs). Consequently, German CPs bear significant responsibility with regard to the availability of oral EC, which is
Kunow C, Priepke C, Langer B.
europepmc +2 more sources
Medical treatment of fibroids: FIGO best practice guidance. [PDF]
Int J Gynaecol ObstetAbstract Even though uterine fibroids are a widespread condition, the range of approved medical treatment options remains limited. In fact, only a few drugs are officially approved for the therapy of fibroids. In both the USA and the European Medicines Agency region, selected gonadotropin‐releasing hormone (GnRH) antagonists have been approved for this
Diaz I, Lumsden MA, Zeppernick M.
europepmc +2 more sources
Pulmonary Leiomyomatosis in a Postmenopausal Patient After Previous Hysterectomy: A Case Report. [PDF]
Case Rep Obstet GynecolObjective Uterine leiomyoma represents one of the most common pathologies affecting women of reproductive age, often presenting with lower abdominal pain and abnormal bleeding. Benign metastasising leiomyomatosis (BML) is a rare tumour originating from uterine leiomyomas, with the lungs being a common extrauterine location.
Varga J, Just K, Ostró A.
europepmc +2 more sources
Treatment of Uterine Fibroid-Related Heavy Menstrual Bleeding: Variations in Clinical Practice at Four Hospitals in the Netherlands. [PDF]
Obstet Gynecol IntIntroduction Uterine fibroids are the most common anatomical cause of heavy menstrual bleeding. To which extent clinical practice variation is present in the treatment of fibroid‐related heavy menstrual bleeding at the hospital level remains unclear. The aim of this study was to identify and evaluate the clinical practice variation in the treatment of ...
Knorren ER +11 more
europepmc +2 more sources
Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine Fibroids [PDF]
Therapeutics and Clinical Risk ManagementAnnika Semmler,1,2,* Maria E de Lange,2,* Joost PH Drenth,3 Niels S Vermeer,4 Pierre M Bet,4 Judith AF Huirne,1,2 Wouter JK Hehenkamp1,2 1Amsterdam Reproduction & Development Research Institute, Amsterdam, the Netherlands; 2Department of ...
Semmler A +6 more
doaj +2 more sources
Immunopharmacology of ulipristal as an emergency contraceptive
International Journal of Women's Health, 2011 Ralph P MiechDepartment of Molecular Pharmacology, Physiology and Biotechnology, Warren Alpert School of Medicine, Brown University, Providence, RI, USAAbstract: A new progesterone antagonist, ulipristal has been made available as an emergency ...
Miech RP
doaj +5 more sources
Do we need a regulatory path for HIV post-exposure prophylaxis? [PDF]
J Int AIDS SocJournal of the International AIDS Society, Volume 28, Issue S1, June 2025.
Miller V, Schaefer R.
europepmc +2 more sources
EClinicalMedicine, 2023 Summary: Background: Heavy menstrual bleeding affects one in four women and negatively impacts quality of life. Ulipristal acetate is prescribed to treat symptoms associated with uterine fibroids.
Lucy H.R. Whitaker +19 more
doaj +1 more source
Pharmacy, 2022 Community pharmacists in Belgium frequently dispense emergency contraceptive pills (ECPs). However, variable and insufficient counseling practices exist across pharmacies, highlighting the need for standardization and quality improvement strategies.
Michael Ceulemans +7 more
doaj +1 more source
Reactions Weekly, 2014 Ein Progesteronrezeptor-Modulator, der zur Notfall-Kontrazeption sowie zur präoperativen Behandlung von Uterusmyomen eingesetzt werden kann. Ob dank Ulipristal weniger oder weniger eingreifende Operationen notwendig sind, wurde jedoch bisher nicht gezeigt.
+4 more sources